EMILY STUART: Open Payments
NPI 1871065201 · GUNTERSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,447 in 72 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,447
Food & beverage: $1,447
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $250 |
| Lilly USA, LLC | 7 | $149 |
| PFIZER INC. | 8 | $149 |
| GlaxoSmithKline, LLC. | 5 | $103 |
| ABBVIE INC. | 4 | $76 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $71 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $70 |
| Lundbeck LLC | 3 | $68 |
| Novo Nordisk Inc | 3 | $59 |
| TOLMAR, INC. | 3 | $55 |
Products named: REXULTI, JARDIANCE, MOUNJARO, NURTEC ODT, AIRSUPRA, Kerendia, FARXIGA, BREZTRI.
Industry payments across AL — which companies pay providers there.
